Global Cancer Gene Therapy Market Research and Forecast 2018-2023 Biotechnology
Healthcare
DEFINITION Gene therapy is a process to treat or prevent disease replacing t he mutated genes with healthy genes. This replacement allows the cells for the production of useful proteins. It can also chang e the way genes are generated. This enables under- or overactiv e genes to operate properly. Gene therapy can be used for expre ssing entirely foreign genes in cells that alter their function or s urvival. During cancer treatment, the genes are replaced for fig hting against carcinogenic tumor cells. Cancer gene therapy ma rket inserts therapeutic DNA into the patient for the treatment of cancer. It is considered to be an effective treatment for cance r as it causes minimum side effects with maximum efficacy.
MARKET MOTIVATORS
• • • •
Rising pool of population with cancer patients Increasing funding in r&d of cancer gene therapy Rising geriatric population base Technological advancement such as car t-cell therapy
MARKET RESTRAINTS
• High cost of treatment
MARKET OPPORTUNITIES
• Untapped market in emerging economies • Partnership & collaborations among the players to develop and launch gene therapy products
REGIONAL ANALYSIS
North America
Europe
APAC
ROW
MARKET SEGMENTATION
By therapy • Gene transfer immunotherapy • Oncolytic virotherapy • Gene induced immunotherpay
MARKET SEGMENTATION
By end users • Hospitals • Research institutes • Biotech companies
COMPANY PROFILES
• • • • •
Achilles therapeutics ltd. Adaptimmune therapeutics plc American gene technologies international inc. Ani pharmaceuticals, inc. Autolus therapeutics plc
To be continued….
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE CONTACT US Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com
10